Bioanalytical Conference

Registration

Your registration options are as follows:

	Register Online. Login in using your user account. If you don't have a user account creating one is free & easy.
	Download the registration form, complete & mail to: July Bioanalytical Conference Extension Services in Pharmacy 777 Highland Avenue Madison, WI 53705
	By phone at 608.262.3130 or toll-free at 877-947-4255 using a credit card for payment.
	Download the registration form, complete & fax to 608.262.2431 using a credit card for payment.

Conference Goals & Objectives

The purpose of this four-day conference is to provide an educational forum to discuss issues and applications associated with the analysis of xenobiotics and metabolites in biological matrices. The conference is designed to include and encourage an open exchange of scientific and methodological applications for bioanalysis similar to existing Land O’ Lakes Conferences. To increase the interactive nature of the conference, the program will be a mixture of lecture, discussion groups and workshops. General goals associated with this conference include:

To provide a better understanding of the bioanalysis of large and small molecule xenobiotics in biological matrices;
To evaluate new techniques and share experiences in the area of xenobiotics;
To gain insight into problems and issues encountered during the drug discovery process and the interface between drug discovery and development;
To discuss current regulatory issues affecting analysis of xenobiotics globally;
To identify processes for improving the identification and quantification of successful drug candidates and their measurement, including in vitro/in vivo implications;
To discuss analytical issues relating to drug metabolism and pharmacokinetic systems and their applicability in drug development activity;
To discuss issues associated with data handling and automation in bioanalytic laboratories;
To gain insight into various perspectives on the drug development process, including industry, academia and regulatory agencies; and
To evaluate the harmonization of methods validation, quality control and set standards for drug metabolite identification in studies involving bioanalysis.

Last years course evaluation results.

Conference Travel Information

Location & Travel

The conference will be presented at Devil's Head Resort in Merrimac, Wisconsin. Merrimac is approximately 40 minutes from Madison. For those registrants flying into Madison, bus transportation will be available to and from Devil's Head Resort.

Shuttle Bus Service to and from the Dane County Regional Airport

Monday 1:30 and 4:30 PM

Friday 10:45 AM

2008 Conference fees

Registration Fee	$1050.00
Lodging & Meals: Single Accommodations	$575.00
Total Amount	$1,625.00
If Payment received prior to June 23, 2008	-$250.00
EARLY REGISTRATION	$1,375.00

NOTE: All accommodations at Devil's Head for conference registrants will be processed through Extension Services in Pharmacy. Fees are based on a single accommodation. Additional fees will be assessed for both lodging in the event more than one person occupies a room.

Enrollment Deadlines/Limits

A check in the total amount payable to UNIVERSITY OF WISCONSIN should accompany your application to ensure that space will be held for you. Credit card payment is also acceptable. Total payment will be returned /refunded if space is not available.

In the event your registration is confirmed and at a later date you are unable to personally attend, a refund (less a $50 administrative fee) will be provided prior to June 23; after June 23, no refunds will be made. You may fax your registration (608) 262-2431 with payment to follow no later than June 23. After June 23, space will not be held without receipt of payment.

Conference Support

Speical thanks for unrestricted educational grant to help support this conference from

PPD Bioanalytical Laboratories Wilmington, NC Middleton, WI
VelQuest Corporation Hopkinton, MA
York Bioanalytical Solutions York, United Kingdom
BioDuro Beijing, China San Diego, CA

Meeting Room

2008 Program Outline

Monday, July 14

6:00pm

Opening Reception

Sponsored by:

MDS Pharma Services
Lincoln, NE

7:00pm

Dinner

Welcomes from Conference Chair & Coordinator

Tuesday, July 15

First Plenary Session: Challenges with Method Development, Qualification and Transfe

Moderator:
Min Chang, Ph.D., Chair
Section Manager, Bioanalytical
Abbott Laboratories, Abbott Park, IL

8:00am

Welcome and Overview

8:15am

Overview to the Challenges with Method Development, Qualification and Transfer

Janice Busch, Ph.D.
Director, Global Head of Clinical Assay, Global Clinical Pharmacology
Pfizer Global Research & Development, Groton, CT

9:15am

Example of a CRO’s Approach to the Challenges

Mario L. Rocci, Jr., Ph.D.
Chief Executive Officer
Prevalere Life Sciences, Inc., Whitesboro, NY

10:00am

Break

10:30am

Example of a Pharma’s Approach to the Challenges

Robert A Dean, Ph.D., M.D.
Medical Fellow II , Diagnostic & Experimental Medicine
Eli Lilly & Company, Indianapolis, IN

11:05am

Discussion

11:15pm

Example of a BioPharm’s Approach to the Challenges

Shabnam Tangri, Ph.D.
Associate Director, Clinical Science and Technology
Biogen Idec, San Diego, CA

11:50am

Discussion

12:00pm

Lunch

Afternoon Session

Moderator:

Douglas J. Turk, Ph.D.
Senior Director, ADME and Bioanalytical
NoAb BioDiscoveries Inc., Mississauga, Ontario, Canada

1:00pm

Statistics Applications for Bioanalytical Data Analysis

Carol Gleason, M.S.
Principal Biostatistician, Global Biometric Sciences, Nonclinical Biostatistics
Bristol-Myers Squibb, Syracuse, NY

2:45pm

Boat tour of the Wisconsin Dells

Sponsor:
PharmaNet Development Group
Princeton, NJ

6:30pm

Dinner

Evening Session

Moderator:

Robert P. Clement, Ph.D.
Senior Director, Bioanalytical and Toxicokinetics
Schering-Plough Research Institute, Lafayette, NJ

8:00pm

Issues with Offshore Bioanalytical Activity

Mark Arnold, Ph.D.
Director, Bioanalytical Sciences Department
Bristol-Myers Squibb Company, New Brunswick, NJ

9:00pm

Dessert Reception

Sponsor:
Tandem Labs
Salt Lake City, UT

Wednesday, July 16

Second Plenary Session – Technologies Applied to Bioanalytical Research

Moderator:
Jo Marie Smolec,Ph.D.,MBA
Senior Director, Immunochemistry
IntertekUSA dba Alta Analytical, San Diego, CA

8:30am

Imaging by MS

Richard Caprioli, Ph.D.
Director, Mass Spectrometry Center
Stanley Cohen Professor of Biochemistry
Professor of Chemistry and Pharmacology
School of Medicine, Vanderbilt University Medical Center, Nashville, TN

9:15am

The Emerging Role of Ion/Ion Chemistry in Bioanalytical Mass Spectrometry

Scott A. McLuckey, Ph.D.
Professor, Analytical Chemistry, Department of Chemistry
Purdue University, West Lafayette, IN

10:00am

Break

10:30am

Determination of siRNA

Michael Beverly, Ph.D.
Research Fellow, RNA Therapeutics
Merck and Company, Boulder, CO

11:15am

Electrochemoluminescence (ECL)

Paul Rhyne, Ph.D.
Group Leader, Clinical Biomarker Development
Bristol-Myers Squibb Company, Pennington, NJ

12:00pm

Lunch

Afternoon Session: Metabolites

Moderator:
Matthew J. Cyronak, M.S.
Director, Bioanalytical
GlaxoSmithKline, King of Prussia, PA

1:00pm

Dealing with Metabolites from an FDA Perspective

Timothy W. Robison, Ph.D., D.A.B.T.
Pharmacologist/Toxicologist, Division of Pulmonary and Allergy Drug Products
CDER, Food and Drug Administration, Silver Spring, MD

1:45pm

Dealing with Metabolites from an Pharma Perspective

Volker Fischer, Ph.D.
Senior Director, GPRD, DMPK and Bioanalysis
Abbott Laboratories, Abbott Park, IL

5:00pm

Poster Session with Authors

5:00pm

Wine and Cheese Reception

Sponsor:
CEDRA Corporation
Austin, TX

6:30pm

Dinner

8:00pm

Round Table Discussions (Optional)

Laboratory Management Issues
Chad Briscoe
Director, Bioanalysis
MDS Pharma Services, Lincoln, NE
Fit-for-purpose Metabolite Assays
Mark Arnold, Ph.D.
Director, Bioanalytical Sciences Department
Bristol-Myers Squibb Company, New Brunswick, NJ
Instrument Qualification
Thomas G. Huggins, Ph.D.
Senior Staff Scientist, Bioanalytical
Procter and Gamble Pharmaceuticals, Mason, OH
Use of Electronic Workbooks
Qin C. Ji, Ph.D.
Senior Director, Bioanalytical Chemistry
Covance Laboratories, Madison, WI
How to Maximize Laboratory Efficiency and Throughput
Danlin Wu, Ph.D.
Senior Director, Bioanalytical
Roche Palo Alto, Palo Alto, CA

Thursday, July 17

Third Plenary Session –Applications of Diagnostics to Bioanalytical Services

Moderator:
Thomas G. Huggins, Ph.D.
Senior Staff Scientist, Bioanalytical
Procter and Gamble Pharmaceuticals, Mason, OH

8:30am

Use of Diagnostic Markers in Translational Medicine

Brad Ackermann, Ph.D.
Senior Research Advisor, Drug Disposition
Eli Lilly and Company, Greenfield, IN

9:15am

Research and Diagnostics: The Next Generation

Hanlan Liu, Ph.D. MBA
Associate Director, DMPK & Pharmaceutics Department
Drug and Biomaterial R & D, Genzyme Corporation, Waltham, MA

10:00am

Break

10:30am

Pharmacokinetics and Pharmacodynamics of Biotech Drugs

Bernd Meibohm, Ph.D., FCP
Professor of Pharmaceutical Sciences
College of Pharmacy, University of Tennessee, Memphis, TN

11:15am

Use of Biomarkers from an Agency Perspective

Federico Goodsaid, Ph.D.
Genomics Group, Office of Clinical Pharmacology
Office of Translational Sciences, Center for Drug Evaluation and Research
Food and Drug Administration, Silver Springs, MD

12:00pm

Lunch

Afternoon Session

1:00pm

Open Forum: Dealing with Daily Problems

Chad Briscoe
Director, Bioanalysis
MDS Pharma Services, Lincoln, NE

Min Chang, Ph.D.
Section Manager, Bioanalytical
Abbott Laboratories, Abbott Park, IL

2:45pm

Tour of the Wollersheim Winery

Sponsored by:
CANTEST Ltd.
Vancouver, BC, Canada

6:00pm

Dinner

Evening Session - Analytical Investigators’ Forum

Moderator
Eric N. Fluhler, Ph.D.
Assistant Vice President
Bioanalytical R&D, Drug Safety and Metabolism
Wyeth Research, Collegeville, PA

7:30pm

Method Development and Validation for Chiral Drugs

Hongliang Jiang, Ph.D.
Staff Scientist, Bioanalytical Chemistry
Covance Laboratories, Madison, WI

8:00pm

Beating the Clock in Analyte Conversion Kinetics: A Tale of a Method Transfer

Corey Ohnmacht, PhD.
R&D Scientist III, Bioanalysis
MDS Pharma Services, Lincoln, NE

Development of Quantitative Ligand Binding Assays in Unusual Matrices

Jacob Levy
Project Analyst, Immunochemistry
Intertek USA dba ALTA Analytical, San Diego, CA

9:00pm

Wisconsin Cheese Boxes

Sponsored by:

Prevalere Life Sciences, Inc.,
Whitesboro, NY

Friday, July 18

Fourth Plenary Session –Regulatory Issues Affecting Bioanalysis

Moderator:
Danlin Wu, Ph.D.
Senior Director, Bioanalytical
Roche, Palo Alto, CA

8:30am

Dealing with Unresolved Questions from Crystal City

William S. Edgemond, Ph.D.
Senior Staff Scientist
CEDRA Corporation, Austin, TX

9:30am

An Update on Compliance Issues

C.T. Viswanathan, Ph.D.
Associate Director, Division of Scientific Investigations
Office of Compliance, Center for Drug Evaluation & Research
U.S. Food & Drug Administration, Rockville, MD

10:30am

Adjournment

2008 Conference Planning Committee

Min S. Chang, Ph.D., Conference Chair, Abbott Laboratories, Abbott Park, IL

Mark Arnold, Ph.D., Bristol-Myers Squibb Company, New Brunswick, NJ

Brian P Booth, Ph.D., Office of Clinical Pharmacology, CDRE, FDA, Silver Spring, MD

Chad Briscoe, MDS Pharma Services, Lincoln, NE

Robert P. Clement, Ph.D., Schering-Plough Research Institute, Lafayette, NJ

Matthew J. Cyronak, GlaxoSmithKline, King of Prussia, PA

Kevin L. Duffin, Ph.D., Eli Lilly and Company, Greenfield, IN

Russell P. Grant, Ph.D., Esoterix, Inc., Calabasas Hills, CA

Michael J. Hayes, Ph.D., Novartis Pharmaceuticals Corporation, East Hanover, NJ

Tom Huggins, Ph.D., Procter and Gamble, Mason, OH

Qin C. Ji, Ph.D., Covance Laboratories, Madison, WI

Joseph W. Pav, Ph.D., Wyeth Research, Collegeville, PA

Jo Marie Smolec,Ph.D.,MBA, Intertek ALTA Analytical, San Diego, CA

John M. Strong, Ph.D., CDER, FDA, Laurel, MD 20708

Douglas J. Turk, Ph.D., NoAb BioDiscoveries Inc., Mississauga, Ontario, Canada

Danlin Wu, Ph.D., Roche Palo Alto, Palo Alto, CA

Social Activities

In addition to the educational benefits of this program, the conference is designed to provide registrants with a relaxing environment to meet and share ideas with colleagues with similar interests and network for future collaborative effort. To this end, Devil's Head Resort offers a variety of activities including tennis, indoor and outdoor swimming pools, mountain bikes, nature trails and one of the finest golf courses in Wisconsin. Golf, at a significantly reduced rate, is available to all registrants during Tuesday and Wednesday afternoons of the conference.

Meeting Room

Click here to view photos from 2007

Continuing Education Credit

Extension Services in Pharmacy (ESP) at the University of Wisconsin-Madison School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmaceutical education. This program is approved for 18 hours or 1.8 continuing education units (CEUs). Pharmacists will be required to complete an evaluation form and statements of credit for continuing pharmaceutical education participation will be mailed within one month of receipt of the evaluation materials. Universal Program Number 073-000-08-022-L04-P

For More Information

James E. De Muth, Ph.D., Conference Director
Extension Services in Pharmacy
777 Highland Avenue
Madison, WI 53705
(608) 262-3130
FAX (608) 262-2431

Send Email

green block

Land O’Lakes Bioanalytical Conference
July 14-18, 2008
Devil’s Head Resort
Merrimac, WI

Menu

POSTER SESSION

2008 Poster Guidelines

Registration

Conference Goals & Objectives